Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Shared and distinct lipid profiles in amygdala from sporadic and GBA-associated Parkinson's diseases.

NPJ Parkinson's disease·2026
Same author

Progress in modelling ATP13A2-linked neurodegeneration.

NPJ Parkinson's disease·2026
Same author

Alzheimer's Tau seeds-induced pathology enhances hippocampal extracellular diffusion.

Communications biology·2025
Same author

Phenotypic characterization of an Atp13a2 knockout rat model of Parkinson's disease.

NPJ Parkinson's disease·2025
Same author

Gliogenesis from the subventricular zone modulates the extracellular matrix at the glial scar after brain ischemia.

eLife·2025
Same author

Position paper: leveraging non-human primate (NHP) specificities to accelerate Parkinson's disease and ageing research.

NPJ Parkinson's disease·2025

Related Experiment Video

Updated: Jun 1, 2026

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
10:03

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Published on: August 16, 2020

α-synuclein, a prion-like protein

Benjamin Dehay

    Movement Disorders : Official Journal of the Movement Disorder Society
    |June 15, 2011
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Monitoring Cell-to-cell Transmission of Prion-like Protein Aggregates in Drosophila Melanogaster
    10:26

    Monitoring Cell-to-cell Transmission of Prion-like Protein Aggregates in Drosophila Melanogaster

    Published on: March 12, 2018

    Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
    09:27

    Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

    Published on: January 5, 2016

    Related Experiment Videos

    Last Updated: Jun 1, 2026

    Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
    10:03

    Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

    Published on: August 16, 2020

    Monitoring Cell-to-cell Transmission of Prion-like Protein Aggregates in Drosophila Melanogaster
    10:26

    Monitoring Cell-to-cell Transmission of Prion-like Protein Aggregates in Drosophila Melanogaster

    Published on: March 12, 2018

    Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
    09:27

    Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

    Published on: January 5, 2016